Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiome Composition Regulates Cathepsin Expression in Vaginal Fluid Across BV Diagnoses and Community State Types.

bioRxiv : the preprint server for biology·2026
Same author

Multilevel Proteomics Reveals Epigenetic Signatures in BCG-Mediated Macrophage Activation.

Molecular & cellular proteomics : MCP·2024
Same author

Ethnic disparity in diagnosing asymptomatic bacterial vaginosis using machine learning.

NPJ digital medicine·2023
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics
07:28

JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics

Published on: October 19, 2021

MPOInt: An Epigenetics-Driven Workflow for Integrative Multi-Level Proteomics.

Zoe Schaefer1, Carleigh Coffin Sokolik1, Ivana K Parker1,2,3

  • 1J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, Florida 32610, United States.

Journal of Proteome Research
|June 18, 2026
PubMed
Summary

This study introduces MPOInt, a bioinformatics pipeline for integrating multiple proteomics data types. This tool helps uncover epigenetic targets in aggressive cancers by providing clinical context to complex proteomic data.

Keywords:
BCGMCF-7bladder cancerbreast cancerdisease enrichmentepigeneticsepiproteomehistonephosphoproteomicsproteomics

More Related Videos

Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling
11:19

Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling

Published on: November 17, 2019

Related Experiment Videos

Last Updated: Jun 19, 2026

JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics
07:28

JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics

Published on: October 19, 2021

Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling
11:19

Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling

Published on: November 17, 2019

Area of Science:

  • Proteomics
  • Epigenetics
  • Bioinformatics

Background:

  • Proteomics offers insights into cellular regulation and epigenetic states in health and disease.
  • Integrating diverse proteomics data (total, phospho, epi) provides a comprehensive system view.
  • Current limitations include isolated data capture and complex bioinformatics for integrative analyses.

Purpose of the Study:

  • To develop a user-friendly pipeline for multidimensional proteomic data integration.
  • To enable the combination of histone proteome data with epigenetic effectors.
  • To identify novel therapeutic targets in aggressive cancers by adding clinical context to proteomic data.

Main Methods:

  • Development of the MPOInt pipeline and associated R package.
  • Integration of various proteomics modalities (total, phospho, epi).
  • Analysis combining proteomic data with pre-existing clinical data.

Main Results:

  • MPOInt facilitates flexible, multidimensional data analysis with a low barrier to entry.
  • Identification of key pathways implicated in aggressive cancer growth, including treatment-resistant breast cancer.
  • Generation of unique networks centered around epigenetic factors.

Conclusions:

  • MPOInt enhances the interpretation of complex proteomic data by adding clinical context.
  • The pipeline aids in discovering potential therapeutic targets for aggressive cancers.
  • This approach facilitates a deeper understanding of epigenetic regulation in disease states.